7RDA
Crystal structure of PfCSP peptide 21 with vaccine-elicited human anti-malaria antibody m43.138
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 22-ID |
Synchrotron site | APS |
Beamline | 22-ID |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2021-04-25 |
Detector | DECTRIS EIGER2 X 16M |
Wavelength(s) | 1 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 60.492, 79.263, 90.922 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 42.510 - 1.920 |
R-factor | 0.1998 |
Rwork | 0.198 |
R-free | 0.23190 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 6b5l |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | PHENIX (1.19.1_4122) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 50.000 | 50.000 | 1.950 |
High resolution limit [Å] | 1.920 | 5.210 | 1.920 |
Rmerge | 0.106 | 0.049 | 0.564 |
Rmeas | 0.115 | 0.054 | 0.613 |
Rpim | 0.044 | 0.020 | 0.235 |
Total number of observations | 235291 | ||
Number of reflections | 33841 | 1854 | 1669 |
<I/σ(I)> | 7 | ||
Completeness [%] | 99.4 | 99.3 | 99.5 |
Redundancy | 7 | 6.4 | 6.5 |
CC(1/2) | 0.998 | 0.893 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 293 | 0.1 M sodium citrate tribasic dihydrate, pH 5.0, 10% w/v PEG6000 |